Sign in

You're signed outSign in or to get full access.

Doug O’Bannon

Research Analyst at Private Investor

Doug O’Bannon is a Research Analyst at Private Investor, with a focus on biotechnology and healthcare sectors. He has specifically covered companies such as Adicet Bio and has engaged in earnings call discussions, demonstrating a targeted approach to emerging biopharma equities. While direct performance metrics and rankings are not publicly available, his participation in corporate research highlights industry engagement and analytical experience. Details about his career timeline, previous firms, and professional credentials such as FINRA registration or securities licenses are not found in available public records.

Doug O’Bannon's questions to Adicet Bio (ACET) leadership

Question · Q1 2019

Doug O’Bannon, a private investor, expressed concern about the falling stock price and asked if the company was worried about the possibility of being de-listed.

Answer

CFO Becky Roof responded directly that the company is not concerned about the stock being de-listed at this point in time.

Ask follow-up questions

Fintool

Fintool can predict Adicet Bio logo ACET's earnings beat/miss a week before the call